Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03647306 · ClinicalTrials.gov registry record · NA

Behavioral Chronotype: Impact on Sleep and Metabolism

A NA study of Cardiovascular Diseases and Type2 Diabetes Mellitus, sponsored by University of Chicago.

Active
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT03647306 is a NA study of Cardiovascular Diseases and Type2 Diabetes Mellitus that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 200 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03647306, a NA study of Cardiovascular Diseases and Type2 Diabetes Mellitus, is active but no longer recruiting, sponsored by University of Chicago.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine how the timing of eating changes how the body makes and uses energy (metabolism). This study will also examine if metabolism changes with age.

Interventions

  • BEHAVIORAL Early Total Caloric Intake
  • BEHAVIORAL Late Total Caloric Intake
  • BEHAVIORAL Extended Overnight Fast

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2018-02-02
Est. Completion 2027-01-01
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT03647306

The ClinicalTrials.gov registry entry for NCT03647306 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 3 interventions - of which Early Total Caloric Intake is the first listed.

NCT03647306 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT03647306 about?

NCT03647306 is a clinical study titled "Behavioral Chronotype: Impact on Sleep and Metabolism". The purpose of this study is to examine how the timing of eating changes how the body makes and uses energy (metabolism). This study will also examine if metabolism changes with age.

What is the current status of trial NCT03647306?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2018-02-02. Estimated completion is 2027-01-01.

What conditions does trial NCT03647306 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Type2 Diabetes Mellitus.

What interventions are being tested in trial NCT03647306?

The interventions under investigation include: Early Total Caloric Intake (BEHAVIORAL), Late Total Caloric Intake (BEHAVIORAL), Extended Overnight Fast (BEHAVIORAL).

Who is sponsoring clinical trial NCT03647306?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03647306 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.